Skip to content

The effect of a bracelet on gastrointestinal recovery after unicompartmental knee arthroplasty

The effect of EmeTerm® bracelet on gastrointestinal reaction following unicompartmental knee arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70004676
Enrollment
240
Registered
2025-01-20
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea, vomiting and constipation in patients undergoing knee replacement Surgery

Interventions

Using an acupoint stimulation bracelet (EmeTerm®) All patients received the same perioperative management and drug treatment. The incidence of PONV at different time points (3, 6, 12 and 24 hours aft

Sponsors

Luoyang Orthopedic-Traumatological Hospital of Henan Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 75 years who need knee replacement due to end-stage osteoarthritis 2. Patients who voluntarily participate in clinical trials and sign informed consent forms with good compliance

Exclusion criteria

Exclusion criteria: 1. Patients undergoing revision and bilateral joint replacement 2. Patients who have received acupuncture treatment within 2 weeks 3. Patients with rheumatoid disease, systemic lupus erythematosus and ankylosing spondylitis 4. Patients with severe deformity of knee joint (knee flexion =30 degrees, varus =30 degrees or valgus =15 degrees) 5. severe hepatic and renal insufficiency 6. Patients with central nervous system or mental illness 7. Those who are experiencing nausea, vomiting, diarrhea or constipation, and those who are taking drugs or non-drugs to treat nausea, vomiting, diarrhea or constipation, and those who are taking drugs that affect gastrointestinal motility 8. Skin allergy, breakage, infection or itching at the test site, etc

Design outcomes

Primary

MeasureTime frame
The incidence of PONV measured using questionnaire at 3, 6, 12 and 24 hours after the operation

Secondary

MeasureTime frame
1. The severity of nausea and vomiting measured using questionnaire in the 24 hours after the operation 2. First exhaust time and defecation time after the operation, measured using questionnaire 3. Levels of hemoglobin, albumin and electrolyte in blood measured using hospital monitoring system after the operation 4. The incidence of constipation measured using questionnaire at 3 days after the operation 5. Stratified analysis on the basis of anesthesia method and the risk of nausea and vomiting

Countries

China

Contacts

Public ContactGuorui Cao
13688172272@163.com+86 (0)13258289917

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026